Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis

Science Translational Medicine, 2020
Rachel Knevel , Saskia le Cessie , Chikashi C. Terao , Kamil Slowikowski , Jing Cui, Tom W. J. Huizinga , Karen H. Costenbader, Katherine P. Liao , Elizabeth W. Karlson, Soumya Raychaudhuri

Abstract

A genetic risk tool could be used at the first clinical visit of patients with inflammatory arthritis to increase diagnostic efficacy.

Reply by Email

Related

Using genetics to differentiate patients with similar symptoms: application to inflammatory arthritis in the rheumatology outpatient clinic
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis